Cencora VP of Emerging Therapies Talks Innovative Order-to-Cash Solutions for Cell and Gene Therapies

In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Melissa Lattanzi, VP, Emerging Therapies, Cencora discusses the process of coming up with can innovative order-to-cash solutions help to maximize market reach.